OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
58 hedge funds and large institutions have $318M invested in Oyster Point Pharma, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
58
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.13M | |
| 2 | +$2.96M | |
| 3 | +$1.05M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$851K |
| 5 |
State Street
Boston,
Massachusetts
|
+$551K |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$2.06M | |
| 3 | -$1.23M | |
| 4 |
LP
Lexington Partners
New York
|
-$501K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$478K |